Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers O > Headlines for Oxford Immunotec Global plc > News item |
Oxford Immunotec Global to price initial public sale of stock
JPMorgan and Piper Jaffray are joint bookrunning managers for deal
By Devika Patel
Knoxville, Tenn., Oct. 15 - Oxford Immunotec Global plc plans to conduct an initial public offering of its ordinary stock with a greenshoe, according to a Form S-1 filed Tuesday with the Securities and Exchange Commission.
JPMorgan and Piper Jaffray are the joint bookrunning managers. Cowen and Co. and Baird are the co-managers.
Proceeds will be used to hire additional sales, marketing and customer service personnel and expand marketing programs, for research and development programs, debt repayment, working capital and other general corporate purposes.
The diagnostics company is based in Abingdon, England. The company intends to list its common stock on the Nasdaq stock exchange under the symbol "OXFD."
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.